Earnings per Share (EPS) (Basic): A company's net earnings or losses attributable to common shareholders per basic share basis.
Arcturus Therapeutics Holdings Inc. (ARCT) had Earnings per Share (EPS) (Basic) of $-0.52 for the most recently reported fiscal quarter, ending 2025-03-31.
Income Statement Financials | |
$29.38M |
|
$-14.08M |
|
-- |
|
$29.38M |
|
$46.21M |
|
$-16.83M |
|
$2.75M |
|
$-14.08M |
|
$-14.08M |
|
$-14.08M |
|
$-14.08M |
|
$-14.08M |
|
$-14.08M |
|
$-16.83M |
|
$-16.02M |
|
27.11M |
|
27.11M |
|
Earnings per Share (EPS) (Basic) |
$-0.52 |
$-0.52 |
|
Balance Sheet Financials | |
$278.79M |
|
$8.87M |
|
$52.99M |
|
$331.79M |
|
$49.41M |
|
$15.00M |
|
$48.62M |
|
$98.03M |
|
$233.76M |
|
$233.76M |
|
$233.76M |
|
27.12M |
|
Cash Flow Statement Financials | |
$-35.14M |
|
$-0.14M |
|
$15.20M |
|
$293.91M |
|
$273.83M |
|
$-20.08M |
|
$6.66M |
|
-- |
|
-- |
|
Fundamental Metrics & Ratios | |
5.64 |
|
-- |
|
-- |
|
0.06 |
|
0.06 |
|
100.00% |
|
-57.27% |
|
-57.27% |
|
-- |
|
-47.91% |
|
-47.91% |
|
$-35.27M |
|
-- |
|
-- |
|
-- |
|
0.09 |
|
-- |
|
2.02 |
|
44.64 |
|
-6.02% |
|
-6.02% |
|
-4.24% |
|
-5.66% |
|
$8.62 |
|
$-1.30 |
|
$-1.30 |